REFERENCES
Selected references published in medical journals within the last years
2022
- Cantey JB, Prusakov P. A Proposed Framework for the Clinical Management of Neonatal “Culture-Negative” Sepsis. J Pediatr 2022;244:203–11. https://doi.org/10.1016/j.jpeds.2022.01.006.
- Reyman M, van Houten MA, Watson RL, Chu MLJN, Arp K, de Waal WJ, et al. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat Commun 2022;13:893. https://doi.org/10.1038/s41467-022-28525-z.
- *Stocker M, Daunhawer I, van Herk W, El Helou S, Dutta S, Schuerman FABA, et al. Machine Learning Used to Compare the Diagnostic Accuracy of Risk Factors, Clinical Signs and Biomarkers and to Develop a New Prediction Model for Neonatal Early-onset Sepsis. Pediatr Infect Dis J 2022;41:248–54. https://doi.org/10.1097/INF.0000000000003344.
- Tiozzo C, Mukhopadhyay S. Noninfectious influencers of early-onset sepsis biomarkers. Pediatr Res 2022;91:425–31. https://doi.org/10.1038/s41390-021-01861-4.
2021
- Achten NB, Plötz FB, Klingenberg C, Stocker M, Bokelaar R, Bijlsma M, et al. Stratification of Culture-Proven Early-Onset Sepsis Cases by the Neonatal Early-Onset Sepsis Calculator: An Individual Patient Data Meta-Analysis. J Pediatr 2021. https://doi.org/10.1016/j.jpeds.2021.01.065.
- Cantey JB, Lee JH. Biomarkers for the Diagnosis of Neonatal Sepsis. Clin Perinatol 2021;48:215–27.https://doi.org/10.1016/j.clp.2021.03.012.
- *Stocker M, van Herk W, El Helou S, Dutta S, Schuerman FABA, van den Tooren-de Groot RK, et al. C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study. Clin Infect Dis Off Publ Infect Dis Soc Am 2021;73:e383–90. https://doi.org/10.1093/cid/ciaa876.
- *Zihlmann-Ji J, Braun C, Buettcher M, Hodel M, Lehnick D, Stocker M. Reduction of Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis in Late-Preterm and Term Newborns After Implementation of a Procalcitonin-Guided Algorithm: A Population-Based Study in Central Switzerland. Front Pediatr 2021;9:702133. https://doi.org/10.3389/fped.2021.702133.
2020
- Frymoyer A, Joshi NS, Allan JM, Cohen RS, Aby JL, Kim JL, et al. Sustainability of a Clinical Examination-Based Approach for Ascertainment of Early-Onset Sepsis in Late Preterm and Term Neonates. J Pediatr 2020;225:263–8. https://doi.org/10.1016/j.jpeds.2020.05.055.
- Kuzniewicz MW, Mukhopadhyay S, Li S, Walsh EM, Puopolo KM. Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis. Pediatr Infect Dis J 2020;39:634–40.https://doi.org/10.1097/INF.0000000000002632.
- *Vatne A, Klingenberg C, Øymar K, Rønnestad AE, Manzoni P, Rettedal S. Reduced Antibiotic Exposure by Serial Physical Examinations in Term Neonates at Risk of Early-onset Sepsis. Pediatr Infect Dis J 2020;39:438–43. https://doi.org/10.1097/INF.0000000000002590.
2019
- Frymoyer A, Joshi NS, Allan JM, Cohen RS, Aby JL, Kim JL, et al. Sustainability of a Clinical Examination-Based Approach for Ascertainment of Early-Onset Sepsis in Late Preterm and Term Neonates. J Pediatr 2020;225:263–8. https://doi.org/10.1016/j.jpeds.2020.05.055.
- Kuzniewicz MW, Mukhopadhyay S, Li S, Walsh EM, Puopolo KM. Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis. Pediatr Infect Dis J 2020;39:634–40.https://doi.org/10.1097/INF.0000000000002632.
- *Vatne A, Klingenberg C, Øymar K, Rønnestad AE, Manzoni P, Rettedal S. Reduced Antibiotic Exposure by Serial Physical Examinations in Term Neonates at Risk of Early-onset Sepsis. Pediatr Infect Dis J 2020;39:438–43. https://doi.org/10.1097/INF.0000000000002590.
2018
- *Culture-negative early-onset sepsis - at the crossroad between efficient sepsis care and antimicrobial stewardship. Klingenberg C, Kornelisse RF, Buoncore G, Maier RF, Stocker M. Front Pediatr 2018:285, 2018
- Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 2018; 6: 223–30.
- *Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study. Giannoni E, Agyeman PKA, Stocker M, Posfay-Barbe KM, Heininger U, Spycher BD, Bernhard-Stirnemann S, Niederer-Loher A, Kahlert CR, Donas A, Leone A, Hasters P, Relly C, Riedel T, Kuehni C, Aebi C, Berger C, Schlapbach LJ; Swiss Pediatric Sepsis Study. J Pediatr. 2018 Jul 24. pii: S0022-3476(18)30761-3. doi: 10.1016/j.jpeds.2018.05.048.
- *Ng S, Strunk T, Jiang P, Muk T, Sangild PT, Currie A. Precision Medicine for Neonatal Sepsis. Front Mol Biosci 2018;5:70. https://doi.org/10.3389/fmolb.2018.00070.
- Stiemsma LT, Michels KB. The Role of the Microbiome in the Developmental Origins of Health and Disease. Pediatrics 2018; 141. DOI:10.1542/peds.2017-2437
2017
- *Efficacy and safety of Procalcitonin-guided decision-making versus standard care for duration of antibiotic therapy in neonates suspected of early-onset sepsis: the NeoPInS study - an international, multicenter, non-inferiority randomized controlled intervention trial. Martin Stocker, Wendy van Herk, Salhab el Helou, Sourabh Dutta, Matteo S Fontana, Frank ABA Schuerman, Rita K van den Tooren-de Groot, Jantien W Wieringa, Jan Janota, Laura H van der Meer-Kappelle, Rob Moonen, Sintha D Sie, Esther de Vries, Albertine E Donker, Urs Zimmerman, Luregn J Schlapbach, Amerik C de Mol, Angelique Hoffman-Haringsma, Madan Roy, Maren Tomaske, René F Kornelisse, Juliette van Gijsel, Eline G Visser, Sten P Willemsen, Annemarie MC van Rossum for the NeoPInS Study Group. Lancet 2017 August 26;390:871-81. doi: 10.1016/S0140-6736(17)31444-7
- Raymond SL, Rincon JC, Wynn JL, Moldawer LL, Larson SD. Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. Front Immunol 2017;8:729. https://doi.org/10.3389/fimmu.2017.00729.
- Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet Lond Engl 2017; 390: 1770–80
2016
- *Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland. Giannoni E, Berger C, Stocker M, Agyeman P, Posfay-Barbe KM, Heininger U, Konetzny G, Niederer-Loher A, Kahlert C, Donas A, Leone A, Hasters P, Relly C, Baer W, Aebi C, Schlapbach LJ; Swiss Pediatric Sepsis Study Group. Pediatr Infect Dis J. 2016 Feb;35(2):222-4. doi: 10.1097/INF.0000000000000974
- *Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial use. van Herk W, Stocker M, van Rossum AM. J Infect. 2016 Jul 5;72 Suppl:S77-82. doi: 10.1016/j.jinf.2016.04.026.
- *Variation in Current Management of Term and Late-preterm Neonates at Risk for Early-onset Sepsis: An International Survey and Review of Guidelines. van Herk W, el Helou S, Janota J, Hagmann C, Klingenberg C, Staub E, Giannoni E, Tissieres P, Schlapbach LJ, van Rossum AM, Pilgrim SB, Stocker M. Pediatr Infect Dis J. 2016 May;35(5):494-500. doi: 10.1097/INF.0000000000001063.
2015
- Mukherjee A, Davidson L, Anguvaa L, Duffy DA, Kennea N. NICE neonatal early onset sepsis guidance: greater consistency, but more investigations, and greater length of stay. Arch Dis Child Fetal Neonatal Ed 2015;100:F248-249. https://doi.org/10.1136/archdischild-2014-306349
2014
- *Duvoisin G, Fischer C, Maucort-Boulch D, Giannoni E. Reduction in the use of diagnostic tests in infants with risk factors for early-onset neonatal sepsis does not delay antibiotic treatment. Swiss Med Wkly 2014;144:w13981. https://doi.org/10.4414/smw.2014.13981.
- Weiss SL, Fitzgerald JC, Balamuth F, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med 2014; 42: 2409–17
2013
- *Recommendations for term and late preterm infants at risk for perinatal bacterial infection. Stocker M, Berger C, McDopugall J, Giannoni E. SMW 2013; 143:w13873
*Members of AENEAS as co-authors